In search of new strategies against life-threatening tuberculosis infections, a team from the Technical University of Munich (TUM), as well as Harvard University and Texas A&M University in the USA have found a new ally. They discovered a substance that interferes with the mycomembrane formation of the bacterium. It is effective even in low concentrations and when combined with known antibiotics their effectiveness is improved by up to 100-fold.
Among the greatest challenges when treating life-threatening tuberculosis infections is the increasing resistance to antibiotics. But the pathogen itself also makes the life of doctors difficult: its dense mycomembrane hampers the effect of many medications. A team of scientists headed by Stephan A. Sieber, Professor of Organic Chemistry at TU Munich, has discovered a substance that perturbs the formation of this membrane significantly.
The mycomembrane of the tuberculosis pathogen Mycobacterium tuberculosis consists of a lipid double layer that encapsulates the cell wall, forming an exterior barrier. Structural hallmarks are mycolic acids, branched beta-hydroxy fatty acids with two long hydrocarbon chains. The team hypothesizes that similarly structured beta lactones could “mask” themselves as mycolic acid to enter the mycolic acid metabolic pathways and then block the decisive enzymes.
In the context of an extensive search, the interdisciplinary team of scientists hit the bullseye with the beta lactone EZ120. It does indeed inhibit the biosynthesis of the mycomembrane and kills mycobacteria effectively. Using enzyme assays and mass spectroscopy investigations, Dr. Johannes Lehmann, a researcher at the Chair of Organic Chemistry II at TU Munich, demonstrated during his doctoral work that the new inhibitor blocks especially the enzymes Pks13 and Ag85, which play a key role in the development of mycomembranes.
EZ120 is effective even in low doses, easily passes the mycomembrane and exhibits only low toxicity to human cells. The combined application of this substance with known antibiotics showed a synergistic effect leading to significantly increased effectiveness.”Vancomycin, a common antibiotic, and EZ120 work together very well,” says Prof. Sieber, who heads the Chair of Organic Chemistry II. “When used together, the dose can be reduced over 100-fold.
“The scientists suspect that disrupting the mycomembrane enables antibiotics to enter the bacteria more easily. This is a new mode of action and might be a starting point for novel tuberculosis therapies.
Learn more: Double strike against tuberculosis
The Latest on: Tuberculosis
Denis Mitchison, groundbreaking tuberculosis researcher – obituary
on July 18, 2018 at 10:03 am
Denis "Denny" Mitchison, who has died aged 98, was part of the research team which developed a treatment regime for tuberculosis and proved its effectiveness through clinical trials in London; he late... […]
Co-Diagnostics Completes Submission of CE Mark Registration for Tuberculosis Screening Test
on July 17, 2018 at 3:30 am
Co-Diagnostics, Inc. CODX, -5.52%, a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ MTB Test ... […]
How many people die from tuberculosis every year?
on July 17, 2018 at 2:36 am
Global TB mortality: this is the correlation between estimates by the WHO and the IHME. Credit: Garcia-Basteiro et al, 2018 The discrepancies between the estimates for global tuberculosis deaths by th... […]
Tuberculosis contact-tracing among Syrian refugee populations: lessons from Jordan
on July 16, 2018 at 9:35 pm
In response to the influx of displaced Syrians since 2011, the Jordanian National Tuberculosis Program (NTP) implemented a specific Tuberculosis (TB) reduction strategy, including contact-tracing (CT) ... […]
Tuberculosis Drugs: Worldwide Market to Grow at 4.8% CAGR during 2018-2024 - Analysis by Disease Type, Drug Class and Region - ResearchAndMarkets.com
on July 16, 2018 at 3:53 am
DUBLIN--(BUSINESS WIRE)--The "Tuberculosis Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The report ... […]
US sanctions fan tuberculosis epidemic in North Korea
on July 14, 2018 at 6:55 am
PYONGYANG, North Korea — Doctor O Yong Il swings open a glass door with a bright orange biohazard sign and gestures to the machine he hoped would revolutionize his life’s work. It’s called the GeneXpe... […]
Plainfield Walmart warehouse employee exposed to tuberculosis at work
on July 13, 2018 at 8:32 am
PLAINFIELD, Ind. -- An employee at a Walmart warehouse in Plainfield, Indiana received a letter saying she was exposed to tuberculosis at work -- but she never heard anything from her employer. "I exp... […]
Tuberculosis continues to pose a deadly threat
on July 10, 2018 at 3:08 pm
A tuberculosis scare at the Johns Hopkins Hospital health system should not be dismissed as a close call [“Workers vacate after possible TB exposure,” Local Digest, July 6]. While those involved in th... […]
Tuberculosis | A Pipeline Analysis Report 2018 | Technavio
on July 10, 2018 at 9:33 am
LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the tuberculosis market. The report includes a detailed analysis of the pipeline molecules under investigation ... […]
How Mycobacterium tuberculosis escapes death in macrophages
on July 10, 2018 at 8:28 am
The bacteria that cause the devastating disease tuberculosis have the ability to escape destruction and grow after they are engulfed by lung macrophages, the immune cells that are supposed to destroy ... […]
via Google News and Bing News